Levodopa + Benserazide
- Mechanism of Action
- Levodopa - a dopamine precursor that is converted to dopamine, which is severely depleted within the striatum pallidum and substantia nigra in Parkinson’s disease.
Benserazide - a decarboxylase inhibitor that inhibits peripheral conversion of levodopa to dopamine.
- Crosses the blood brain barrier.
- Parkinson’s disease.
- Adverse Effects
- Involuntary movements
- Nausea / vomiting
- Postural hypotension
Want more info like this?
- Your electronic clinical medicine handbook
- Guides to help pass your exams
- Tools every medical student needs
- Quick diagrams to have the answers, fast
- Quizzes to test your knowledge